The FDA approved Omisinge (omidubicel-onlv) to quicken the recovery of white blood cells in the body and reduce the risk of infection after umbilical cord blood transplantation following radiation or chemotherapy.
Do you know how to say the generic name?
Oh-mih-DOO-buh-sel--Oh-En-
You are viewing a robot-friendly page.Click hereto reload in standard format.